Literature DB >> 15528031

Ethacrynic-acid-induced glutathione depletion and oxidative stress in normal and Mrp2-deficient rat liver.

Bin Ji1, Kousei Ito, Shuichi Sekine, Ai Tajima, Toshiharu Horie.   

Abstract

Oxidative stress in the liver is sometimes accompanied by cholestasis. We investigated the localization and role of multidrug-resistance-associated protein (Mrp) 2, a biliary transporter involved in bile-salt-independent bile flow, under ethacrynic acid (EA)-induced acute oxidative stress. Normal Sprague-Dawley rat (SDR) and Mrp2-deficient Eisai hyperbilirubinemic rat (EHBR) livers were perfused with 500 microM EA. The release of glutamic pyruvic transaminase (GPT) and thiobarbituric-acid-reactive substances (TBARS) from EHBR liver was markedly delayed compared with that from SDR liver. This is mainly due to the higher basal level of glutathione (GSH) in EHBR liver (59.1 +/- 0.3 nmol/mg protein) compared with SDR liver (39.7 +/- 1.5 nmol/mg protein). EA similarly induced a rapid reduction in GSH followed by mitochondrial permeability transition in the isolated mitochondria from both SDR and EHBR. Internalization of Mrp2 was detected before nonspecific disruption of the canalicular membrane and GPT release in SDR liver perfused with 100 microM EA. SDR liver preperfused with hyperosmolar buffer (405 mosmol/L) for 30 min induced internalization of Mrp2 without changing the basal GSH level, while elimination of hepatic GSH by 300 microM EA perfusion was significantly delayed thereafter. Concomitantly, hepatotoxicity assessed by the release of GPT and TBARS was also significantly attenuated under hyperosmolar conditions. In conclusion, preserved cytosolic and intramitochondrial GSH is the key factor involved in the acute hepatotoxicity induced by EA and its susceptibility could be altered by the presence of Mrp2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528031     DOI: 10.1016/j.freeradbiomed.2004.08.020

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  7 in total

1.  Nonalcoholic Steatohepatitis Modulates Membrane Protein Retrieval and Insertion Processes.

Authors:  A L Dzierlenga; J D Clarke; N J Cherrington
Journal:  Drug Metab Dispos       Date:  2016-09-07       Impact factor: 3.922

2.  Effects of ginsenosides on the expression of cytochrome P450s and transporters involved in cholesterol metabolism.

Authors:  Atsushi Kawase; Ayano Yamada; Yuko Gamou; Chika Tahara; Fumiaki Takeshita; Kazuya Murata; Hideaki Matsuda; Keiichi Samukawa; Masahiro Iwaki
Journal:  J Nat Med       Date:  2013-07-09       Impact factor: 2.343

Review 3.  Dynamic localization of hepatocellular transporters in health and disease.

Authors:  Marcelo G Roma; Fernando A Crocenzi; Aldo D Mottino
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

4.  Effects of High-cholesterol Diet on Pravastatin Disposition in the Perfused Rat Liver.

Authors:  Atsushi Kawase; Ayumi Handa; Masahiro Iwaki
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

5.  Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease.

Authors:  Rhiannon N Hardwick; Craig D Fisher; Mark J Canet; George L Scheffer; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2011-08-30       Impact factor: 3.922

6.  Cellular pharmacokinetic and pharmacodynamic analyses of ethacrynic acid: Implications in topical drug delivery in the eye.

Authors:  Cheng-Wen Lin; Pedro Gonzalez; Fan Yuan
Journal:  Mol Vis       Date:  2011-09-27       Impact factor: 2.367

7.  The Protective Effect of Edaravone on TDP-43 Plus Oxidative Stress-Induced Neurotoxicity in Neuronal Cells: Analysis of Its Neuroprotective Mechanisms Using RNA Sequencing.

Authors:  Aki Soejima-Kusunoki; Kinya Okada; Ryuta Saito; Kazuhiko Watabe
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.